Biomay Cooperates with BioNTech to Supply DNA Template for COVID-19 mRNA Vaccine
(May 17th, 2021) Biomay, a Vienna based biotech manufacturer, today announced their partnership with BioNTech SE to support the supply chain for manufacturing of the Pfizer-BioNTech COVID-19 mRNA vaccine.
> More infoConstruction Project of Biomay’s Manufacturing Facility Fully on Schedule
(May 12th, 2021) Construction work on Biomay’s new headquarters and biotech manufacturing facility in Aspern Seestadt, Vienna, is progressing on schedule. Seven months after the groundbreaking ceremony …
> More infoBiomay to Construct a New Biotech Manufacturing Facility in Vienna
(December 15th, 2020) Biomay, a Vienna-based biotech company, is constructing a new production facility which will increase its manufacturing capacities tenfold and its headcount almost twofold. The new headquarters in Aspern Seestadt, Vienna …
> More infoBIA Separations and Biomay collaborate on production and purification of large DNA plasmids
(May 16th, 2018) BIA Separations, a leading biochromatography development and manufacturing company, and Biomay, a contact manufacturer of cGMP biopharmaceuticals, today announced a collaboration on the high-yield production of large DNA plasmids.
> More infoBiomay and RBPS-Technologies Sign Agreement for GMP Minicircle DNA
(July 27th, 2009) Biomay and RBPS-Technologies announce their manufacturing cooperation for production of GMP-grade minicircle DNA. The companies are now offering a contract manufacturing service to third parties to supply minicircles in both clinical quality for use in clinical trials and research quality.
> More info